AU771275B2 - Treatment of diabetic nephropathy and microalbuminuria - Google Patents

Treatment of diabetic nephropathy and microalbuminuria Download PDF

Info

Publication number
AU771275B2
AU771275B2 AU40235/01A AU4023501A AU771275B2 AU 771275 B2 AU771275 B2 AU 771275B2 AU 40235/01 A AU40235/01 A AU 40235/01A AU 4023501 A AU4023501 A AU 4023501A AU 771275 B2 AU771275 B2 AU 771275B2
Authority
AU
Australia
Prior art keywords
individual
salviae miltiorrhizae
diabetic
level
miltiorrhizae radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU40235/01A
Other languages
English (en)
Other versions
AU4023501A (en
Inventor
Mankil Jung
Hyun Chul Lee
Hai-Ri Li
Sudhir V. Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiva Biomedical LLC
Original Assignee
Shiva Biomedical LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiva Biomedical LLC filed Critical Shiva Biomedical LLC
Publication of AU4023501A publication Critical patent/AU4023501A/en
Application granted granted Critical
Publication of AU771275B2 publication Critical patent/AU771275B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU40235/01A 1999-09-29 2000-09-21 Treatment of diabetic nephropathy and microalbuminuria Ceased AU771275B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/408,436 US6149915A (en) 1999-09-29 1999-09-29 Treatment of diabetic nephropathy and microalbuminuria
US09/408436 1999-09-29
PCT/US2000/025783 WO2001022981A1 (en) 1999-09-29 2000-09-21 Treatment of diabetic nephropathy and microalbuminuria

Publications (2)

Publication Number Publication Date
AU4023501A AU4023501A (en) 2001-04-30
AU771275B2 true AU771275B2 (en) 2004-03-18

Family

ID=23616291

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40235/01A Ceased AU771275B2 (en) 1999-09-29 2000-09-21 Treatment of diabetic nephropathy and microalbuminuria

Country Status (7)

Country Link
US (3) US6149915A (cg-RX-API-DMAC7.html)
EP (1) EP1218020A1 (cg-RX-API-DMAC7.html)
JP (1) JP2003510286A (cg-RX-API-DMAC7.html)
CN (1) CN1387439A (cg-RX-API-DMAC7.html)
AU (1) AU771275B2 (cg-RX-API-DMAC7.html)
CA (1) CA2386000A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001022981A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6149915A (en) * 1999-09-29 2000-11-21 Shiva Biomedical, Llc Treatment of diabetic nephropathy and microalbuminuria
DE10229180A1 (de) 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
WO2005063232A1 (en) * 2003-12-30 2005-07-14 Md Bioalpha Co., Ltd. Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity
US8029829B2 (en) 2005-02-03 2011-10-04 Taiyo Kagaku Co., Ltd. Preventive, relieving or therapeutic composition for diabetes mellitus and/or diabetic nephropathy
CN100341581C (zh) * 2005-07-29 2007-10-10 上海第二医科大学附属第九人民医院 一种丹酚酸b有效干预口腔癌动物模型的方法
US20070027209A1 (en) * 2005-08-01 2007-02-01 Lee Hyun C Prevention and treatment of atherosclerosis with lithospermate B
JP5169818B2 (ja) * 2006-03-07 2013-03-27 日本新薬株式会社 育毛剤
WO2008117901A1 (en) 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University A method for isolation of high concentration of magnesium lithospermate b from salviae miltiorrhizae
US9345732B2 (en) 2009-11-19 2016-05-24 Laila Nutraceuticals Agents derived from Holoptelea integrifolia and their compositions for the control of metabolic syndrome and associated diseases
CN102550916A (zh) * 2012-02-04 2012-07-11 王姗思 一种用于糖尿病肾病的食品
CN102614267A (zh) * 2012-04-24 2012-08-01 许风国 一种治疗糖尿病肾病的中药组合物及其制备方法
CN103830496A (zh) * 2014-02-28 2014-06-04 廊坊市思科农业技术有限公司 一种辅助降糖的组合物
CN104974119B (zh) * 2014-04-01 2018-10-19 中国科学院上海药物研究所 一种高纯度丹酚酸b镁及其制备方法
CN104547498A (zh) * 2014-12-31 2015-04-29 黎细乐 一种中药组合物的新用途
US20160361288A1 (en) * 2015-06-10 2016-12-15 Postech Academy-Industry Foundation Pharmaceutical compositions for preventing or treating diabetic nephropathy comprising the activity inhibitor of tenc1
CN105311413A (zh) * 2015-11-18 2016-02-10 暨南大学 治疗糖尿病肾病的含有艾叶的中药组合物及其制备方法
CN107551172A (zh) * 2017-10-26 2018-01-09 马雪英 一种治疗肾病综合症的药物及其制备方法
CN110215449A (zh) * 2019-05-13 2019-09-10 中国科学院长春应用化学研究所 紫草酸在抑制胰岛素淀粉样多肽聚集中的应用
CN112190646B (zh) * 2020-11-19 2021-12-28 首都医科大学附属北京中医医院 一种治疗糖尿病肾病的中药组合物及其制备方法
CN112569313B (zh) * 2020-12-28 2022-02-22 贵州三力制药股份有限公司 治疗肾病的中药组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01268682A (ja) * 1988-04-21 1989-10-26 Minofuaagen Seiyaku Honpo:Goushi 腎機能改善剤及びリソスペルミン酸塩の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358962A (en) * 1993-04-22 1994-10-25 Minophagen Pharmaceutical Company Antihypertensive method
JP3638967B2 (ja) * 1993-06-03 2005-04-13 日本ケミカルリサーチ株式会社 ネフローゼ症候群及び肝障害症状の寛解剤
JP3161882B2 (ja) * 1993-06-03 2001-04-25 日本ケミカルリサーチ株式会社 丹参由来多糖類、その製造法および用途
FI943242A7 (fi) * 1993-07-15 1995-01-16 Jcr Pharmaceutical Co Ltd Lääke munuais- ja maksatauteihin
US6149915A (en) * 1999-09-29 2000-11-21 Shiva Biomedical, Llc Treatment of diabetic nephropathy and microalbuminuria

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01268682A (ja) * 1988-04-21 1989-10-26 Minofuaagen Seiyaku Honpo:Goushi 腎機能改善剤及びリソスペルミン酸塩の製造方法

Also Published As

Publication number Publication date
JP2003510286A (ja) 2003-03-18
US6267992B1 (en) 2001-07-31
WO2001022981A1 (en) 2001-04-05
US6149915A (en) 2000-11-21
CA2386000A1 (en) 2001-04-05
AU4023501A (en) 2001-04-30
CN1387439A (zh) 2002-12-25
US20020025347A1 (en) 2002-02-28
EP1218020A1 (en) 2002-07-03

Similar Documents

Publication Publication Date Title
US6267992B1 (en) Treatment of diabetic nephropathy and microalbuminuria
Gupta et al. Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats
Tang et al. Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury
Li et al. Dexmedetomidine attenuates myocardial ischemia‐reperfusion injury in diabetes mellitus by inhibiting endoplasmic reticulum stress
Yang et al. Beneficial effects of ginsenoside-Rg1 on ischemia-induced angiogenesis in diabetic mice
CN102091083B (zh) 一种防治糖脂代谢紊乱的中药石油醚提取物及其制备方法
Adeyemi et al. Hibiscus sabdariffa renews pancreatic β-cells in experimental type 1 diabetic model rats
Zhou et al. Chrysin improves diabetic nephropathy by regulating the AMPK‐mediated lipid metabolism in HFD/STZ‐induced DN mice
CN113181150A (zh) Sr1078在制备治疗酒精性肝损伤药物方面的应用、药物组合物
Zhang et al. Tangduqing granules attenuate insulin resistance and abnormal lipid metabolism through the coordinated regulation of PPARγ and DGAT2 in type 2 diabetic rats
Guo et al. BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease
Huang et al. Ophiopogonin D ameliorates non‑alcoholic fatty liver disease in high‑fat diet‑induced obese mice by improving lipid metabolism, oxidative stress and inflammatory response
CN102861201B (zh) 一种治疗糖尿病的药物组合物及其制备方法
CN102631358A (zh) 虎杖苷在制备糖尿病肾病治疗药物中的应用
CN114569613A (zh) 蝙蝠葛生物碱类化合物在治疗代谢性疾病中的应用
CN119745925A (zh) 肝组织源性细胞外囊泡在治疗酒精性肝疾病中的应用
Lv et al. Network Pharmacology‐Based Approach to Explore the Total Flavonoids of Phellinus igniarius against Hyperuricemia via Regulating the Nrf2/HO‐1‐ROS‐ER Signaling Pathway
CN119424436A (zh) 化合物rociletinib通过抑制铁死亡在制备急性肝损伤的药物中的应用
Xu et al. Effects of compound active peptides on protecting liver and intestinal epithelial cells from damages and preventing hyperglycemia
Kurumatani et al. Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
Wu et al. Clerodendranthus spicatus-Cordyceps cicadae regulates mitophagy and protects renal tubular epithelial cells from hyperuricemic nephropathy
Jiang et al. Effects of 95% ethanol extract of Aquilaria sinensis leaves on hyperglycemia in diabetic db/db mice
Oka et al. Effect of Hachimijiogan against Renal Dysfunction and Involvement of Hypoxia‐Inducible Factor‐1α in the Remnant Kidney Model
CN114848621A (zh) 赖氨酸在制备用于抑制或治疗百草枯中毒的药物中的用途
CN120695051B (zh) 狭苞橐吾醇提物在制备预防或治疗药物性肝损伤的药物中的应用

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)